Allotment of scrip shares to Directors

RNS Number : 4441B

The MedicX Fund Limited

03 April 2013

 



Press Release

For immediate release                                                                                    

3 April 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Directors of the Company

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the March 2013 interim dividend for the quarter ended 31 December 2012, and accordingly acquired ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below.  The Shares were sold out of treasury by the Company at the previously advised scrip calculation price of 77.43 pence per Share.

	Shares Acquired	Total Shares held	Percentage Holding
David Staples (Chairman)	1,115	61,733	0.024%
Shelagh Mason	318	17,608	0.007%
John Hearle	364	20,162	0.008%

The Shares were acquired on 28 March 2013 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

End

For further information please contact:

MedicX Group                                                                    [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity                                                              [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan                                                                          [phone]

Charles Ryland/Sophie McNulty/Helen Greenwood

MedicX Fund Limited                                                          [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 107 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

 The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCKMGGDRFVGFZG